PIPgen an Innovative Training Network funded by the European Union’s Horizon 2020 research and innovation programme under the Grant Agreement Nº955534 has officially started on the 1st of July 2021.  PIPgen stands for PI3K/PTEN-related monogenic disease to understand cancer, and the project aims to enhance the understanding of the PI3K/PTEN pathway in both pathological scenarios cancer and monogenic rare diseases.